Evidence for Cerebellar-Frontal Subsystem Changes in Children Treated With Intrathecal Chemotherapy for Leukemia

Abstract
INTRATHECAL methotrexate impairs proliferation of leptomeningeal leukemic cells, and is a major component of preventive central nervous system (CNS) treatment for childhood acute lymphoblastic leukemia (ALL).1 Reported neuroanatomical changes following methotrexate treatment include cerebral calcifications and atrophy,2,3 and children treated with both cranial irradiation (240 Gy) and methotrexate chemotherapy before the age of 5 years have shown decreases in measures of cerebellar morphology.4,5

This publication has 1 reference indexed in Scilit: